Erudio Healtherudio.com
Drug
Futibatinib trials: what clinicians said in public
No HCP commentary report on a trial studying futibatinib yet. Erudio has found public clinician commentary on 4 clinical trials studying futibatinib: BoB, FOENIX-CCA2, NCT04601857 and TAPUR. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| TAPUR NCT02693535 · American Society of Clinical Oncology DeepView → | advanced solid tumors, non-Hodgkin lymphoma or multiple myeloma | Phase 2 | Deep | View | |||
| FOENIX-CCA2 NCT02052778 · Taiho Oncology, Inc. DeepView → | advanced solid tumors harboring FGF/FGFR aberrations | Phase 1/Phase 2 | Deep | View | |||
| NCT04601857 NCT04601857 · Taiho Oncology, Inc. FocusedView → | advanced or metastatic urothelial carcinoma | Phase 2 | Focused | View | |||
| BoB NCT03767075 · Vall d'Hebron Institute of Oncology FocusedView → | molecularly selected advanced solid tumors | Phase 2 | Focused | View | |||